FDA Investigator Helen R Bester
Helen R Bester has inspections in 3 countries as of 29 Aug 2023. Helen R Bester has collaborated with a combinined 2489 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
84
Last Inspection Date:
29 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada
Co-Investigator(s):
Aaron P Wozniak,
Amanda L Evanco,
Amy A Johnson,
Amy H Ruble,
Anita R Michael,
Ann Marie Montemurro,
Annette A Ragosta,
Annette Melendez,
April R Bowen,
Arie C Menachem,
Babatunde D Babalola,
Barbara D Wright,
Barbara T Carmichael,
Bonita S Chester,
Brandon L Mariner,
Brandy D Brown,
Brentley S Collins,
Brian A Graves,
Brian S Lynch,
Burnell M Henry,
Calvin Foulks,
Cara M Minelli,
Carl E Lovrich,
Carol F Robinson,
Carol J Blackwood,
Chateryl K Washington,
Cheryl D Barton,
Christina H Owens,
Christopher J Adams,
Claudele S Razo,
Claudette D Brooks,
Cody D Rickman,
Cordelia J Brammer,
Cynthia Jim, CSO,
Dawn M Braswell,
Debra J Tucker,
Dellarese L Herbert,
Derek C Price,
Devaughn Edwards,
Dionne D Arline,
Doretha M Tonkins,
Doretha M Wilson,
Douglas F Frazier,
Dr. Gang Wang, PhD,
Edecia A Richards,
Edward Deberry,
Eileen J Bannerman,
Eliezar Ramos,
Ernest H Blackwood,
Esra Toussaint,
Eural E Porter,
Fabian Nchaparro Rodriguez,
Fulton A Varner,
Gail L Katz,
Gary E Coleman, Jr, REHS,
Gene D Arcy,
Helen B Ricalde,
Holly M Scott,
Hristu B Chepa,
Ibad U Khan,
Inga M Warr,
Jackie M Douglas,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
Jana L Caylor,
Janet B Gray,
Jessica Fields,
Joanne Pryzbylik,
Joe A Odom,
Jonathan G Matrisciano,
Julie D Bringger,
Karen A Coleman,
Kelley L Clark,
Kenneth L Smalls,
Kimberly Cdelk Brooks,
Kip J Hanks,
Latonya T Jiggetts,
Laurel A Beer,
LCDR Debra Emerson,
Leena Thomas,
Leslie W Gilbert,
Linda Thai,
Lorenzo Jones,
Lori A Holmquist,
Marian A Kainer,
Marion Michaelis,
Mariza M Jafary,
Marla A Cassidy,
Mary A Millner,
Mary Alice Papdimitriou,
Megan K Robinson,
Melanie M Walker,
Melanie W Pishnery,
Miaja Umaedi,
Michael R Goga,
Michelle D Haamid,
Mihaly S Ligmond,
Mizanne E Lewis,
Mpris Inspector,
Myla D Chapman,
Myoshi M Francis,
Nancy L Neiger,
Nawab A Siddiqui,
Nicholas M Smith,
Omotunde O Osunsanmi,
Pamela L Vega,
Patricia F Hudson,
Paul A Bonneau,
Paul W Moy,
Paula A Trost,
Paula J Bretz,
Prabhu P Raju,
Randy L Clarida,
Rhonda Alexander,
Richard J Bashay,
Richard L Garcia,
Robert W Fisher,
Ronnie E Jackson,
Rose M Ashley,
Russell R Zablan,
Sayeeda Hdabe,
Sharna D Pratt,
Sheryl A Kochman,
Shusheen A Alexander,
Shwnji Susie Lee,
Stardust Mazzariello,
Stardust W Mazzariello,
Stephanie E Hubbard,
Stephanie Harrell,
Stephen D Brown,
Susan M Jackson,
Susan Yu,
Tammara A Stephens,
Thao Le,
Theressa B Smith,
Tracy R Ball,
Trang N Cox,
Valerie J Grecek Trinh,
Vanessa E Coulter,
Vincent M Williams,
Wella Wang,
Xiomara Copeland
Helen R Bester's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2000 | FDA 483 | The American National Red Cross South Carolina Region - Form 483, 2000-08-18 |
April, 2002 | EIR | Artivion, Inc - EIR, 2002-04-12 |
January, 2000 | FDA 483 | American Red Cross - Form 483, 2000-01-26 |
April, 2002 | FDA 483 | Artivion, Inc - Form 483, 2002-04-12 |
March, 2002 | EIR | Regenerative Biologics Inc. - EIR, 2002-03-21 |
March, 2002 | FDA 483 Response | Regenerative Biologics Inc. - Form 483R, 2002-04-16 |
October, 2002 | FDA 483 | Walter L. Shepeard Community Blood Center, Inc. - Form 483, 2002-10-09 |
October, 2000 | FDA 483 | American Red Cross Blood Services Carolinas Region - Form 483, 2000-06-30 |
October, 2000 | FDA 483 | American National Red Cross (The) Carolinas Region - Form 483, 2000-07-26 |
October, 2002 | FDA 483 Response | Walter L. Shepeard Community Blood Center, Inc. - Form 483R, 2002-11-12 |
March, 2002 | FDA 483 | Regenerative Biologics Inc. - Form 483, 2002-03-21 |
April, 2002 | FDA 483 Response | Artivion, Inc - Form 483R, 2002-05-15 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more